Both in human and experimental malaria, enhanced TLR activation is suggested to prime proinflammatory cytokine responses (IL-12, IFN-γ, TNF-α), which in turn can favor host hyperresponsiveness to TLR agonists during acute malaria. The gene discussed is TNF; the disease is malaria.